U.S. Markets open in 5 mins
  • S&P Futures

    4,404.50
    -9.75 (-0.22%)
     
  • Dow Futures

    34,911.00
    -123.00 (-0.35%)
     
  • Nasdaq Futures

    15,110.25
    -7.50 (-0.05%)
     
  • Russell 2000 Futures

    2,195.90
    -17.50 (-0.79%)
     
  • Crude Oil

    71.86
    -0.05 (-0.07%)
     
  • Gold

    1,804.50
    +5.30 (+0.29%)
     
  • Silver

    25.21
    -0.11 (-0.43%)
     
  • EUR/USD

    1.1826
    +0.0018 (+0.1537%)
     
  • 10-Yr Bond

    1.2460
    -0.0300 (-2.35%)
     
  • Vix

    18.57
    +1.37 (+7.97%)
     
  • GBP/USD

    1.3823
    -0.0001 (-0.0042%)
     
  • USD/JPY

    109.8970
    -0.4780 (-0.4331%)
     
  • BTC-USD

    38,437.92
    +110.97 (+0.29%)
     
  • CMC Crypto 200

    913.56
    -1.93 (-0.21%)
     
  • FTSE 100

    7,001.88
    -23.55 (-0.34%)
     
  • Nikkei 225

    27,970.22
    +136.93 (+0.49%)
     

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of 1Life Healthcare, Inc. (Nasdaq - ONEM)

·2 min read

BALA CYNWYD, PA / ACCESSWIRE / June 8, 2021 / Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of1Life Healthcare, Inc. ("1Life Healthcare" or the "Company") (Nasdaq - ONEM) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the agreement to acquire Iora Health ("Iora"). Under the terms of the merger agreement, Iora shareholders will receive 56.1 million shares of 1Life Healthcare and will own approximately 26.75% of the combined company if the deal is consummated.

The investigation concerns whether the 1Life Healthcare breached its fiduciary duties to shareholders, including the dilution of 1Life Healthcare shareholders' interest in the combined company.

If you own shares of 1Life Healthcare stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, Two Bala Plaza, Suite 805, Bala Cynwyd, PA 19004, visit https://www.brodskysmith.com/cases/1life-healthcare-inc-nasdaq-onem/, or call toll free 855-576-4847.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

SOURCE: Brodsky & Smith, LLC



View source version on accesswire.com:
https://www.accesswire.com/650912/SHAREHOLDER-NOTICE-Brodsky-Smith-Announces-an-Investigation-of-1Life-Healthcare-Inc-Nasdaq--ONEM